Neuromuscular disorders : NMD, 2017-10, Vol.27 (10), p.918-922
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Memory B cell resurgence requires repeated rituximab in myasthenia gravis
- Ist Teil von
- Neuromuscular disorders : NMD, 2017-10, Vol.27 (10), p.918-922
- Ort / Verlag
- England: Elsevier B.V
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • We examined immunological reactions in two MG cases treated with rituximab (RTX). • RTX treatment led to sustained clinical improvement. • Disease activity was associated with the repopulation of memory B cells. • Additional RTX should be prescribed upon resurgence of memory B cells.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0960-8966eISSN: 1873-2364DOI: 10.1016/j.nmd.2017.06.012Titel-ID: cdi_proquest_miscellaneous_1917961130
- Format
- –
- Schlagworte
- Adult, Anti-acetylcholine receptor antibody, Autoantibodies - blood, B-Lymphocytes - drug effects, Female, Flow cytometer, Humans, Immunoglobulins, Intravenous - therapeutic use, Immunologic Factors - therapeutic use, Memory B cell, Middle Aged, Myasthenia gravis, Myasthenia Gravis - drug therapy, Myasthenia Gravis - immunology, Neurology, Receptors, Cholinergic - immunology, Refractory, Rituximab, Rituximab - therapeutic use, Treatment Outcome